June 8, 2017August 24, 2022
Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows
News
Patients with unresectable or metastatic melanoma who were treated with Keytruda (pembrolizumab) in a pivotal clinical trial showed superior and sustained time ... Read more
June 6, 2017
New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test
News
Castle Biosciences presented three abstracts on the validity of using its 31-Gene Expression Profile (GEP) Test for melanoma prognosis at the ... Read more
June 1, 2017June 2, 2017
Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer
News
Biothera Pharmaceuticals will present the detailed study design of the IMPRIME-1 clinical trial at the upcoming 2017 ASCO Annual Meeting June 2-6 in ... Read more
May 30, 2017
Researchers Provide New Insights into Melanoma Immune Resistance
News
A new study presents detailed information into the processes used by cancer cells to evade and resist the immune response. Researchers studied ... Read more
May 25, 2017May 25, 2017
New Clinical Trial Underway for Treatment of Advanced Melanoma
News
A new clinical trial is underway assessing the addition of the first-in-class AXL kinase inhibitor, BGB324, to standard of care treatment for patients with ... Read more
May 23, 2017May 23, 2017
Skin Cancer Awareness Month Brings Sun Safety to Schools
News
Educating people of all ages, particularly children, about the dangers of sun exposure is urgent to preventing the increased prevalence ... Read more
May 18, 2017
First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma
News
The first patient has been enrolled in Targovax‘s pilot clinical trial for advanced or unresectable melanoma patients whose cancer progressed after treatment ... Read more
May 16, 2017
ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial
News
The combination of ImmunoPulse IL-12 and the anti-PD-1 therapy Keytruda (pembrolizumab) soon will be tested in a Phase 2 trial for treatment ... Read more
May 11, 2017
Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial
News
Adding the small molecule MEK inhibitor binimetinib to the BRAF inhibitor encorafenib was safe and significantly prolonged the time to disease progression ... Read more
May 9, 2017May 9, 2017
Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize
News
The Pershing Square Sohn Cancer Research Alliance has announced the six winners of the fourth edition of the annual Pershing ... Read more
May 4, 2017
Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma
News
Castle Biosciences’ DecisionDx-Melanoma test can be used to accurately predict cancer recurrence and metastasis in patients with head and neck melanoma, ... Read more
April 25, 2017
IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group
News
Prima Biomed, an Australian biotechnology company developing immunotherapies for cancer and autoimmune diseases, announced it has received approval for the ... Read more

August 14, 2014August 14, 2014

Metastatic Merkel Cell Carcinoma Therapy To Be Tested in Worldwide Clinical Trial

News, Skin Cancer

EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, has announced the beginning of an international Phase II multi-center, international, single-arm, open-label clinical trial, designed to evaluate the efficacy and ... Read more

August 13, 2014August 13, 2014

Pen-Sized Probe Offers Next-Generation Approach to Skin Cancer Detection

News, Skin Cancer

A new device allowing an early non-invasive examination of melanoma and other skin cancer lesions has been developed by a team of researchers from the University of Texas at Austin’s Cockrell ... Read more

August 12, 2014August 12, 2014

Researchers Offer New Insight Into Adjuvant Therapy for Stage III Melanoma

Melanoma, News

Even though the incidence of malignant melanoma is increasing, the majority of cases are diagnosed at an early stage. In this setting, surgery is the best option, proving to be ... Read more

August 11, 2014August 11, 2014

Galectin Reports On Phase 1 Clinical Trial To Determine The Effectiveness Of Combined Therapies In Metastatic Melanoma Treatment

Melanoma, News

Galectin Therapeutics Inc., a pharmaceutical company focused on developing treatment options for patients with life-threatening fibrosis or cancer diagnoses, recently announced its first Phase 1 human-trial cohort, testing Galectin protein inhibitor GR-MD-02 ... Read more

August 8, 2014August 8, 2014

Advanced Dermatology & Cosmetic Surgery Supports Call to Action For Prevention Of Skin Cancer

News, Skin Cancer

After the United States Surgeon General recently called on health advocates to act on the prevention of skin cancer, addressing it as a major public health problem, the founder and CEO of ... Read more

August 5, 2014August 7, 2014

Debate Continues on the Future Role of Checkpoint Inhibitors in Melanoma

Melanoma, News

The future role of checkpoint inhibitors in melanoma has been the topic of recent discussion amongst oncologists, as reported in a recent OncLive video debate. Tolerability and the development of predictive ... Read more

August 5, 2014August 5, 2014

Marin County California Experiences High Rates Of Melanoma

Melanoma, News

The Cancer Prevention Institute of California and the Stanford Cancer Institute recently noted that the incidence of melanoma in Marin County, California is rapidly increasing in comparison to other regions of the ... Read more

August 4, 2014August 4, 2014

Researchers Discover New Approach Identifying Cancer Mutation Targets For Novel Melanoma Immunotherapy

Melanoma, News

A team of researchers from the National Cancer Institute (NCI), in Bethesda, Maryland, has developed a novel approach demonstrating that mutated cancer antigens recognized by T-cells are responsible for complete ... Read more

July 31, 2014July 31, 2014

Bristol-Myers Squibb Plans Submission of a Biologics License Application for Previously Treated Advanced Melanoma Drug Opdivo

Melanoma, News

Bristol-Myers Squibb plans to submit a Biologics License Application in the third quarter for its drug Opdivo for previously treated advanced melanoma, following discussions with the U.S. Food and Drug Administration, ... Read more

July 30, 2014July 30, 2014

Roche Announces Effectiveness and Safety of Novel Combination Drug Treatment for Melanoma

Melanoma, News

Swiss biotech company Roche has announced the development of a skin cancer medication treatment that has shown in a late-stage test to be effective in helping advanced patients live longer without disease ... Read more

July 30, 2014July 31, 2014

CNIO Researchers Discover More Than 40 Genes That Determine Melanoma Aggressiveness

Melanoma, News

Researchers at the Spanish National Cancer Research Center (CNIO, in the Spanish abbreviation) have identified over 40 genes that can predict the level of aggressiveness of melanoma, while distinguishing it ... Read more

July 28, 2014July 28, 2014

Melanoma Research Alliance Part of Three-Part Partnership To Further Research On Brain Metastases

Melanoma, News

A leading research funding and advocacy group for Melanoma is teaming up with two other cancer research foundations with a completely different cancer focus to pool resources for researching and ... Read more

Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

Researchers Provide New Insights into Melanoma Immune Resistance

New Clinical Trial Underway for Treatment of Advanced Melanoma

Skin Cancer Awareness Month Brings Sun Safety to Schools

First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma

ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial

Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial

Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize

Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma

IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group